Phenobarbital
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Phenobarbital and local guidelines before prescribing.
Mechanism
Barbiturate enhancing GABA-A activity.
Uses
Seizures (including neonatal), status epilepticus (later line), alcohol withdrawal (selected).
Dosing
- Carbamazepine, phenytoin, phenobarbital, topiramate | Malformations (NTDs, cleft lip and palate, heart defects); topiramate — cleft lip, low birth weight, possible neurodevelopmental effects; lamotrigine and levetiracetam are preferred (with folic acid 5 mg)
Obstetrics
Side effects
Sedation, cognitive slowing, respiratory depression, rash, osteomalacia, dependence.
Interactions
Strong CYP inducer reducing levels of warfarin, contraceptives, DOACs, many drugs.
Contraindications and cautions
Respiratory depression, porphyria
Monitoring
Level, sedation, FBC
Pregnancy and breastfeeding
Teratogenic; specialist advice
Renal and hepatic impairment
Reduce dose in renal and hepatic impairment
Overdose and reversal
Supportive; alkaline diuresis
Special advice
Long half-life; levels useful; avoid abrupt withdrawal.
More from the textbook: uses, cautions and other points
- Crigler–Najjar syndrome: Severe lack of the same enzyme - high unconjugated bilirubin in infants. Type 1 risks kernicterus (phototherapy, transplant). Type 2 responds to phenobarbital.
Gastroenterology: Liver disease - … phenytoin, lacosamide, oxcarbazepine), block calcium channels (ethosuximide - T-type, for absence; gabapentin, pregabalin), boost GABA (benzodiazepines, phenobarbital, valproate, vigabatrin), bind SV2A (levetiracetam, brivaracetam), or block glutamate (perampanel, topiramate). Several act in more than one way.
Neurology: Anatomy, Physiology and Pharmacology - Brand consistency (MHRA categories) - keep patients on the same manufacturer for category 1 drugs ( phenytoin, carbamazepine, phenobarbital, primidone ); use clinical judgement for category 2 (valproate, lamotrigine, topiramate, oxcarbazepine, clobazam, others).
Neurology: Anatomy, Physiology and Pharmacology - Third line (refractory status, usually at about 30–60 minutes): General anaesthesia in ICU (e.g. propofol or midazolam infusion) with EEG monitoring, or phenobarbital.
Neurology: Emergencies - Prescribe by brand for some drugs (category 1 - carbamazepine, phenytoin, phenobarbital, primidone ) to avoid switching between products.
Neurology: Epilepsy - Enzyme-inducing drugs (carbamazepine, oxcarbazepine, phenytoin, phenobarbital, topiramate, eslicarbazepine) make the combined pill, progestogen-only pill and implant unreliable.
Neurology: Epilepsy
Where it is discussed in the book
- Gastroenterology: Liver disease (1 mention)
- Neurology: Anatomy, Physiology and Pharmacology (4 mentions)
- Neurology: Emergencies (1 mention)
- Neurology: Epilepsy (2 mentions)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Palliative: End of Life Care (1 mention)
- Paediatrics: Neonatology (2 mentions)
- Obstetrics (1 mention)
- Gynaecology: Fertility Contraception Menopause (1 mention)
- Dermatology: Urticaria, drug reactions, blistering, ulcers and emergencies (1 mention)
- Clinical pharmacology and prescribing: Principles of clinical pharmacology (3 mentions)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Adverse drug reactions, interactions and drug allergy (1 mention)
- Clinical pharmacology and prescribing: Poisoning and overdose (3 mentions)
- Critical care: common problems, ethics and recovery (1 mention)
- Integrated paediatrics chapter (2 mentions)